Bloomberg Businessweek
Bloomberg Markets: Adviser Backs Dumping Mylan Board
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:11:00
- Mas informaciones
Informações:
Sinopsis
Bloomberg Markets with Carol Massar and Cory Johnson. GUEST: Cynthia Koons Healthcare Reporter Bloomberg News Discussing Mylan NV facing an increasing backlash over its handling of the EpiPen pricing controversy, as a top proxy adviser urged shareholders to oust the drugmaker’s board.
